Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
Category:
10 March 2020
PHARMANUTRA S.P.A SUPPORTING THE NATIONAL HEALTH SERVICE IN THIS EMERGENCY
05 March 2020
PHARMANUTRA S.P.A. LANCIA LA NUOVA CAMPAGNA MULTICANALE āFATTI TROVARE PRONTOā DEDICATA AD APPORTALĀ®.
07 February 2020
NEW AGREEMENTS FOR THE DISTRIBUTION OF SIDERALĀ® IN MEXICO, THE CZECH REPUBLIC AND SLOVAKIA
03 February 2020
PHARMANUTRA S.P.A.: CORPORATE EVENTS CALENDAR 2020
16 January 2020
PHARMANUTRA S.P.A. PRESENTE ALLA SECONDA EDIZIONE DELLāāITALIAN MID CAP CONFERENCEā DI MEDIOBANCA.
08 January 2020
PharmaNutra S.p.A. engages Mediobanca S.p.A. as Specialist
08 January 2020
Food supplement market is growing in Italy and SiderALĀ® Forte 20 capsules is the most sold nutritional supplement in the country.
19 December 2019
MEDIOBANCA ā BANCA DI CREDITO FINANZIARIO S.P.A. STARTS SHARE COVERAGE
28 November 2019
ONGOING INTERNATIONAL EXPANSION FOR THE GROUP, STRENGTHENED BY NEW PATENTS APPROVED
19 November 2019
JUNIA PHARMA SRL LAUNCHES BLEFARENE BABY ON THE MARKET
12 November 2019
PHARMANUTRA S.P.A. OBTAINS PATENT FOR A NEW COMPOSITION USED FOR TREATING CARDIOVASCULAR DISEASES
08 November 2019
PharmaNutra was exhibiting at CPhI Worldwide 2019 in Frankfurt
05 November 2019
PHARMANUTRA OBTAINS THE SOLID IRON PATENT FOR THE USA
22 October 2019
PHARMANUTRA AT THE AIM ITALIA CONFERENCE DRIVEN BY THE POSITIVE ANALYST FORECASTS
17 September 2019
PHARMANUTRA S.P.A.: RESULTS OF THE FIRST SEMESTER CONFIRM GROWTH IN DOUBLE FIGURES
10 September 2019
PHARMANUTRA S.P.A. NEW AGREEMENT SIGNED WITH WERT PHILIPPINES FOR THE SIDERALĀ® RANGE
28 August 2019
NEW AGREEMENT FOR THE DISTRIBUTION OF THE SIDERAL LINE IN TAIWAN
02 August 2019
HISTORICAL MONTH-BASED SALES RECORD IN ITALY
29 July 2019
Anticipated information on the preliminary consolidated revenues of the first half of 2019
16 July 2019
PharmaNutra S.p.A., results come from research
05 July 2019
CetilarĀ® once again the Main Sponsor of Parma Calcio for the 2019/2020 season
<
1
…
7
8
9
…
11
>
